Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome

Am J Respir Crit Care Med. 2023 Aug 1;208(3):222-224. doi: 10.1164/rccm.202306-0969ED.

Authors

Haibo Zhang^{1

2

3

4}, Arthur S Slutsky^{1

4}

Affiliations

¹ The Keenan Research Centre for Biomedical Science of St. Michael's Hospital Toronto, Ontario, Canada.
² Department of Anesthesiology and Pain Medicine.
³ Department of Physiology.
⁴ Interdepartmental Division of Critical Care Medicine University of Toronto Toronto, Ontario, Canada.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Humans
Mesenchymal Stem Cells*
Respiratory Distress Syndrome* / etiology
Respiratory Distress Syndrome* / therapy
SARS-CoV-2
Stromal Cells

Grants and funding